Larimar Therapeutics, Inc. (LRMR)
2.695
-0.04
(-1.28%)
USD |
NASDAQ |
Nov 12, 16:00
2.695
0.00 (0.00%)
After-Hours: 17:33
Larimar Therapeutics Market Cap : 281.31M for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 11, 2026 | 284.97M |
| November 10, 2026 | 280.79M |
| November 09, 2026 | 264.09M |
| November 06, 2026 | 249.48M |
| November 05, 2026 | 242.17M |
| November 04, 2026 | 288.10M |
| November 03, 2026 | 265.13M |
| November 02, 2026 | 247.39M |
| October 30, 2026 | 257.83M |
| October 29, 2026 | 278.70M |
| October 28, 2026 | 265.13M |
| October 27, 2026 | 249.48M |
| October 26, 2026 | 233.82M |
| October 23, 2026 | 245.30M |
| October 22, 2026 | 236.95M |
| October 21, 2026 | 252.61M |
| October 20, 2026 | 254.69M |
| October 19, 2026 | 221.29M |
| October 16, 2026 | 207.20M |
| October 15, 2026 | 207.72M |
| October 14, 2026 | 218.16M |
| October 13, 2026 | 225.47M |
| October 12, 2026 | 264.09M |
| October 09, 2026 | 278.70M |
| October 08, 2026 | 281.83M |
| Date | Value |
|---|---|
| October 07, 2026 | 287.05M |
| October 06, 2026 | 290.18M |
| October 05, 2026 | 298.54M |
| October 02, 2026 | 308.97M |
| October 01, 2026 | 319.41M |
| September 30, 2026 | 333.50M |
| September 29, 2026 | 327.76M |
| September 28, 2026 | 330.89M |
| September 25, 2026 | 320.98M |
| September 24, 2026 | 346.55M |
| September 23, 2026 | 403.44M |
| September 22, 2026 | 398.74M |
| September 21, 2026 | 399.79M |
| September 18, 2026 | 395.61M |
| September 17, 2026 | 396.66M |
| September 16, 2026 | 410.22M |
| September 15, 2026 | 408.14M |
| September 14, 2026 | 394.57M |
| September 11, 2026 | 409.18M |
| September 10, 2026 | 401.87M |
| September 09, 2026 | 403.96M |
| September 08, 2026 | 425.36M |
| September 04, 2026 | 399.79M |
| September 03, 2026 | 399.79M |
| September 02, 2026 | 403.96M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.132B |
| Alnylam Pharmaceuticals, Inc. | 20.96B |
| Anika Therapeutics, Inc. | 185.37M |
| Savara, Inc. | 968.08M |
| Vericel Corp. | 2.930B |
Market Cap Related Metrics
| PEG Ratio | -0.0503 |
| Price to Book Value | 2.208 |
| Price | 2.695 |
| Earnings Yield | -73.58% |
| PEGY Ratio | -0.0503 |